Ng Wai Yan, Ching Chor Kwan, Chong Yeow Kuan, Ng Sau Wah, Cheung Wing Lan, Mak Tony Wing Lai
Hospital Authority Toxicology Reference Laboratory, Princess Margaret Hospital, Kowloon, Hong Kong, People's Republic of China.
J Med Toxicol. 2018 Sep;14(3):218-228. doi: 10.1007/s13181-018-0660-x. Epub 2018 Apr 23.
Warfarin- and superwarfarin-type anticoagulants are commonly used as rodenticides. Exposure to these agents, especially superwarfarins with long-acting anticoagulant effect, can cause life-threatening coagulopathy in humans. Most superwarfarin poisoning cases had an obvious history of exposure, though occult cases without exposure history have also been reported. The current study aims to examine anticoagulant-type rodenticide poisoning in Hong Kong and to identify the similarities and differences between patients with known exposure history and those whose exposure is recognized only through laboratory testing.
The present study was conducted in a tertiary referral clinical toxicology laboratory in Hong Kong. This was a retrospective cohort study of all patients with biochemically confirmed anticoagulant-type rodenticide exposure, from 2010 to 2014.
Superwarfarin was the most common group of anticoagulant-type rodenticides identified (87.8%), in which bromadiolone and brodifacoum were the most frequently encountered. Among the 41 cases identified, 31 had an obvious exposure history, and 10 were occult poisoning in which the context of exposure remained unidentified. All occult poisoning patients without exposure history presented with bleeding events. These occult poisoning cases often went unrecognized by frontline clinicians, leading to delayed investigation and initiation of treatment. This group of patients was associated with a longer time to diagnose coagulopathy (p < 0.001) and confirm rodenticide poisoning (p < 0.05), a higher rate of international normalized ratio (INR) rebound after initiation of antidote (p < 0.001), and a longer time needed for normalizing INR (p < 0.05).
Occult superwarfarin poisoning is an important yet under-recognized differential cause of unexplained coagulopathy. A high index of clinical suspicion and availability of specialized toxicological test for superwarfarins play a vital role in diagnosis and early initiation of appropriate management. The underlying cause of such poisoning remains obscure and warrants further study.
华法林和超级华法林类抗凝剂常用作灭鼠剂。接触这些药剂,尤其是具有长效抗凝作用的超级华法林,可导致人类出现危及生命的凝血病。大多数超级华法林中毒病例有明显的接触史,不过也有报道称存在无接触史的隐匿性病例。本研究旨在调查香港地区抗凝剂类灭鼠剂中毒情况,并确定有已知接触史的患者与仅通过实验室检测才被确认接触的患者之间的异同。
本研究在香港一家三级转诊临床毒理学实验室进行。这是一项对2010年至2014年所有经生化确认接触抗凝剂类灭鼠剂的患者进行的回顾性队列研究。
超级华法林是最常见的被确认的抗凝剂类灭鼠剂(87.8%),其中溴敌隆和溴鼠灵最为常见。在确认的41例病例中,31例有明显的接触史,10例为隐匿性中毒,接触情况不明。所有无接触史的隐匿性中毒患者均出现出血事件。这些隐匿性中毒病例往往未被一线临床医生识别,导致调查和治疗延迟。这组患者诊断凝血病的时间较长(p<0.001),确认灭鼠剂中毒的时间较长(p<0.05),使用解毒剂后国际标准化比值(INR)反弹率较高(p<0.001),使INR恢复正常所需时间较长(p<0.05)。
隐匿性超级华法林中毒是不明原因凝血病的一个重要但未被充分认识的鉴别病因。高度的临床怀疑以及超级华法林的专业毒理学检测对诊断和尽早开始适当治疗起着至关重要的作用。此类中毒的根本原因仍不清楚,值得进一步研究。